2gd3
From Proteopedia
(Difference between revisions)
Line 6: | Line 6: | ||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=2gd3 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2gd3 OCA], [http://www.rcsb.org/pdb/explore.do?structureId=2gd3 RCSB], [http://www.ebi.ac.uk/pdbsum/2gd3 PDBsum]</span></td></tr> | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=2gd3 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2gd3 OCA], [http://www.rcsb.org/pdb/explore.do?structureId=2gd3 RCSB], [http://www.ebi.ac.uk/pdbsum/2gd3 PDBsum]</span></td></tr> | ||
</table> | </table> | ||
+ | == Function == | ||
+ | [[http://www.uniprot.org/uniprot/HUNIN_HUMAN HUNIN_HUMAN]] Plays a role as a neuroprotective factor. Protects against death induced by multiple different familial Alzheimer disease genes and beta amyloid proteins in Alzheimer disease. Suppresses apoptosis by binding to BAX and preventing the translocation of BAX from the cytosol to mitochondria. Binds to IGFBP3 and specifically blocks IGFBP3-induced cell death Induces chemotaxis of mononuclear phagocytes via FPR2. Reduces the aggregation and fibrillary formation by suppressing the effect of APP on mononuclear phagocytes and acts by competitively inhibiting the access of FPRL1 to APP.<ref>PMID:11371646</ref> <ref>PMID:14561895</ref> <ref>PMID:11717357</ref> <ref>PMID:12732850</ref> <ref>PMID:15153530</ref> | ||
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
Line 18: | Line 20: | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
- | [[Category: Benaki, D | + | [[Category: Benaki, D]] |
- | [[Category: Evangelou, A | + | [[Category: Evangelou, A]] |
- | [[Category: Livaniou, E | + | [[Category: Livaniou, E]] |
- | [[Category: Mikros, E | + | [[Category: Mikros, E]] |
- | [[Category: Pelecanou, M | + | [[Category: Pelecanou, M]] |
- | [[Category: Vlassi, M | + | [[Category: Vlassi, M]] |
- | [[Category: Zikos, C | + | [[Category: Zikos, C]] |
[[Category: Alzheimer's disease]] | [[Category: Alzheimer's disease]] | ||
[[Category: Cd]] | [[Category: Cd]] |
Revision as of 06:46, 24 December 2014
NMR structure of S14G-humanin in 30% TFE solution
|
Categories: Benaki, D | Evangelou, A | Livaniou, E | Mikros, E | Pelecanou, M | Vlassi, M | Zikos, C | Alzheimer's disease | Cd | Humanin | Neuroprotection | Nmr | S14g-humanin | Unknown function